Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Research into Oral Semaglutide and Heart Failure Outcomes
February 2026
The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.
Read more
9
Mins
12 Oct 2017
Arrhythmogenic Cardiomyopathy: Genetic Pathology, Inflammatory Syndrome, or both?
Arrhythmogenic cardiomyopathy (ACM) affects mainly young athletes <35 years old and has a potential risk of malignant arrhythmias and sudden death.
9
Mins
12 Oct 2017
Cardiac Cachexia Syndrome
This review gathers evidence to enable recognition of cardiac cachexia and improve identification of patients with terminal heart failure.
19 Sep 2017
ESC 2017 – Opening Ceremony
Our full congress review of ESC 2017 will be available soon for free in our Cardiology 5.1 eJournal, but here is a look at the opening ceremony while you…
19 Sep 2017
ESC 2017 – Congress Highlights
Here is a look at this year’s congress highlights, and grab our full congress review of ESC 2017 in EMJ’s Cardiology 5.1 eJournal, coming soon.
9
Mins
31 Aug 2017
Treatment Options in Cardiogenic Shock with Intra-Aortic Balloon Counterpulsation
Cardiogenic shock (CS), a state of inadequate tissue perfusion due to cardiac dysfunction, remains the leading cause of death following acute myocardial…
30 Aug 2017
Study Results: Titanium-Nitride-Oxide (TiNO) Coated Stent Is Non-Inferior to Bioabsorbable Polymer Everolimus-Eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)
Barcelona, 29 August, 2017 – During the Late Breaking Science session at the European Society of Cardiology (ESC) Congress in Barcelona, Dr. Pim Tonino…
7 Aug 2017
Link Established Between Iron Status and Coronary Artery Disease
IRON may have protective qualities against heart disease, suggests a new study examining iron levels in relation to coronary artery disease (CAD), by a…
15 Jun 2017
What’s Happened and Where next for ASV? In Heart Failure and Out of Heart Failure
Anita Simonds explains the latest clinical evidences about ASV in Heart Failure.
Loading posts...
« Previous
1
…
75
76
77
78
79
…
96
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View